Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The remarkable speed of development of safe and effective SARS-CoV-2 vaccines was a success of this pandemic. In this chapter, we discuss how these vaccines were distributed across the globe. The pandemic was characterized by significant variety of vaccine public policies and a broad spectrum of stringency of policy. The reasons for these disparities include ideological differences in the role of government, the affordability of vaccines for a given country, regional variations in epidemiology, and different policy aims (e.g., suppression vs. mitigation). In addition, global vaccine inequity was an unfortunate and pervasive issue and vaccine hesitancy impacted implementation. Evaluation of vaccine policies during this pandemic provides some key lessons to inform future pandemic policy, and for vaccine roll out for diseases with more predictable epidemiology.

Original publication

DOI

10.1016/B978-0-443-19170-1.00029-2

Type

Chapter

Book title

Understanding the Pandemic: Pathophysiology, Transmission, and Treatment of COVID-19

Publication Date

01/01/2024

Pages

805 - 817